Cellbxhealth PLC Announces Holding(s) in Company 
Aspire BioPharma Welcomes Dr. Mark J. Jaroszeski as New Scientific Team Member
ESTERO, FL / ACCESS Newswire / November 26, 2025 / Aspire Biopharma Holdings, Inc. (NASDAQ:ASBP) ("Aspire" or the "Company"), a...
Aspire BioPharma Welcomes Dr. Mark J. Jaroszeski as New Scientific Team Member
ESTERO, FL / ACCESS Newswire / November 26, 2025 / Aspire Biopharma Holdings, Inc. (NASDAQ:ASBP) ("Aspire" or the "Company"), a...
Sannabis, Inc. (OTC: USPS) Announces Binational Hemp Block Initiative Designed to Strengthen U.S.-Colombia Relations Through Sustainable Industrial Development
New Industry Aims to Create U.S. Manufacturing Jobs While Supporting Colombian Farmers Transitioning to Legal, High-Value Hemp Production CALI, COLOMBIA...
Sannabis, Inc. (OTC: USPS) Announces Binational Hemp Block Initiative Designed to Strengthen U.S.-Colombia Relations Through Sustainable Industrial Development
New Industry Aims to Create U.S. Manufacturing Jobs While Supporting Colombian Farmers Transitioning to Legal, High-Value Hemp Production CALI, COLOMBIA...
VSee Health, Inc. Announces Pricing of $6.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules with a Single Institutional Investor
SAN JOSE, CALIFORNIA / ACCESS Newswire / November 26, 2025 / VSee Health, Inc. (NASDAQ:VSEE), a leader in innovative telemedicine...
VSee Health, Inc. Announces Pricing of $6.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules with a Single Institutional Investor
SAN JOSE, CALIFORNIA / ACCESS Newswire / November 26, 2025 / VSee Health, Inc. (NASDAQ:VSEE), a leader in innovative telemedicine...
Wellgistics Health Announces Sponsorship of Dream Bowl 2026 and Participation in DataVault AI Dream Bowl 2026 Meme Coin Shareholder Distribution Plan
Company plans to distribute Dream Bowl 2026 Meme Coin to shareholders as of a to-be-determined December 2025 date with distribution...
Wellgistics Health Announces Sponsorship of Dream Bowl 2026 and Participation in DataVault AI Dream Bowl 2026 Meme Coin Shareholder Distribution Plan
Company plans to distribute Dream Bowl 2026 Meme Coin to shareholders as of a to-be-determined December 2025 date with distribution...
AIML Subsidiary NeuralCloud Signs Commercial Term Sheet With Equimetrics To Deploy Maxyield(TM) And Cardioyield(TM) Across Equine Cardiac Monitoring Platforms
Agreement expands NeuralCloud's AI-enhanced ECG signal-processing technology into veterinary health and elite equine performance marketsCommercial integration expands MaxYield™ and CardioYield™...
AIML Subsidiary NeuralCloud Signs Commercial Term Sheet With Equimetrics To Deploy Maxyield(TM) And Cardioyield(TM) Across Equine Cardiac Monitoring Platforms
Agreement expands NeuralCloud's AI-enhanced ECG signal-processing technology into veterinary health and elite equine performance marketsCommercial integration expands MaxYield™ and CardioYield™...
Join ProPhase Labs’ Exclusive Live Investor Webinar and Q&A Session on December 1
UNIONDALE, NY, Nov. 26, 2025 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH) is pleased to invite investors to a...
SciSparc to Acquire Treasury of Patents for Innovative Medical Endoscopy Systems
TEL AVIV, Israel, Nov. 26, 2025 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) (“Company” or “SciSparc”), a company engaged in...
Altimmune to Participate in the Piper Sandler 37th Annual Healthcare Conference
GAITHERSBURG, Md., Nov. 26, 2025 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a late clinical-stage biopharmaceutical company developing novel peptide-based...
Repligen Corporation to Present at Evercore Healthcare Conference
WALTHAM, Mass., Nov. 26, 2025 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership,...
Anavex Life Sciences to Present Oral Blarcamesine Data at the 18th Clinical Trials on Alzheimer’s Disease (CTAD) Conference
One Oral Late Breaking Communication and Two Poster PresentationsNEW YORK, Nov. 26, 2025 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp....
Silexion Therapeutics to Present at Noble Capital Markets’ 21st Annual Emerging Growth Equity Conference
Grand Cayman, Cayman Islands, Nov. 26, 2025 (GLOBE NEWSWIRE) -- Silexion Therapeutics Corp. (“Silexion” or the “Company”), a clinical-stage, oncology-focused...
BioNTech Shares Progress on Exchange Offer for CureVac Shares and Highlights December 3, 2025, at 9:00 a.m. Eastern Time Expiration
Offer set to expire at 9:00 am Eastern Time on December 3, 2025, with CureVac shareholders advised to tender their...
Celcuity To Present at Upcoming 8th Annual Evercore Healthcare Conference
MINNEAPOLIS, Nov. 26, 2025 (GLOBE NEWSWIRE) -- Celcuity Inc. (Nasdaq: CELC), a clinical-stage biotechnology company pursuing development of targeted therapies...
Herantis Pharma announces successful completion of six-month GLP toxicology study of HER-096
Key step achieved in advancing HER-096 towards Phase 2 efficacy trial Espoo, Finland, 26 November 2025: Herantis Pharma Plc (“Herantis”),...
CG Oncology Announces New Board Member and Board Transition
- Appoints Accomplished Life Sciences Executive Christina Rossi to its Board of Directors - IRVINE, Calif., Nov. 26, 2025 (GLOBE...